(Q112200906)
Statements
Mechanism of action of Tarloxotinib, a hypoxia-activated pan-HER inhibitor: Potential for targeting wild-type EGFR in non-small cell lung cancer (English)
0 references
2017
0 references
2017 doctoral thesis by Shevan Silva at University of Auckland
No description defined